| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a60559e5784c59f0119d0cf1c3455f2b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C59-62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-103
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6848
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-487
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-483
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C59-62 |
| filingDate |
2007-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdf3821f947dd5c6da57b9ac5f0851be |
| publicationDate |
2009-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20090013207-A |
| titleOfInvention |
Biomarker for diagnosis of multiple sclerosis and method of manufacturing the same |
| abstract |
The present invention describes diagnostic methods and differential diagnosis for various forms of multiple sclerosis. This method measures the strength of specific small molecules, called metabolites, in samples obtained from patients diagnosed with multiple sclerosis in clinically relapsing-remitting or primary-advanced forms, and these strengths are determined as healthy markers for identification of multiple sclerosis. Compare with the intensity observed in Also provided are methods for diagnosing subjects suffering from relapsing-remitting multiple sclerosis from secondary-progressive multiple sclerosis. |
| priorityDate |
2006-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |